[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Monensin (CAS 17090-79-8) Market Growth 2022-2028

March 2022 | 108 pages | ID: G048768C89D4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Monensin (CAS 17090-79-8) will have significant change from previous year. According to our (LP Information) latest study, the global Monensin (CAS 17090-79-8) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Monensin (CAS 17090-79-8) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Monensin (CAS 17090-79-8) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Monensin (CAS 17090-79-8) market, reaching US$ million by the year 2028. As for the Europe Monensin (CAS 17090-79-8) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Monensin (CAS 17090-79-8) players cover Elanco, Zoetis, Huvepharma, and Virbac, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Monensin (CAS 17090-79-8) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • 10% Monensin
  • 20% Monensin
  • 40% Monensin
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Cattle
  • Sheep
  • Chicken
  • Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • Elanco
  • Zoetis
  • Huvepharma
  • Virbac
  • Merck Animal Health
  • Ceva Animal Health
  • Phibro Animal Health
  • Agrihealth
  • Qilu Pharmaceutical
  • CAHIC
  • Biok Biology
  • Bio Agri Mix
  • Animate Animal Health
  • Baoxiang Feed Technology
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Monensin (CAS 17090-79-8) Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Monensin (CAS 17090-79-8) by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Monensin (CAS 17090-79-8) by Country/Region, 2017, 2022 & 2028
2.2 Monensin (CAS 17090-79-8) Segment by Type
  2.2.1 10% Monensin
  2.2.2 20% Monensin
  2.2.3 40% Monensin
2.3 Monensin (CAS 17090-79-8) Sales by Type
  2.3.1 Global Monensin (CAS 17090-79-8) Sales Market Share by Type (2017-2022)
  2.3.2 Global Monensin (CAS 17090-79-8) Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Monensin (CAS 17090-79-8) Sale Price by Type (2017-2022)
2.4 Monensin (CAS 17090-79-8) Segment by Application
  2.4.1 Cattle
  2.4.2 Sheep
  2.4.3 Chicken
  2.4.4 Others
2.5 Monensin (CAS 17090-79-8) Sales by Application
  2.5.1 Global Monensin (CAS 17090-79-8) Sale Market Share by Application (2017-2022)
  2.5.2 Global Monensin (CAS 17090-79-8) Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Monensin (CAS 17090-79-8) Sale Price by Application (2017-2022)

3 GLOBAL MONENSIN (CAS 17090-79-8) BY COMPANY

3.1 Global Monensin (CAS 17090-79-8) Breakdown Data by Company
  3.1.1 Global Monensin (CAS 17090-79-8) Annual Sales by Company (2020-2022)
  3.1.2 Global Monensin (CAS 17090-79-8) Sales Market Share by Company (2020-2022)
3.2 Global Monensin (CAS 17090-79-8) Annual Revenue by Company (2020-2022)
  3.2.1 Global Monensin (CAS 17090-79-8) Revenue by Company (2020-2022)
  3.2.2 Global Monensin (CAS 17090-79-8) Revenue Market Share by Company (2020-2022)
3.3 Global Monensin (CAS 17090-79-8) Sale Price by Company
3.4 Key Manufacturers Monensin (CAS 17090-79-8) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Monensin (CAS 17090-79-8) Product Location Distribution
  3.4.2 Players Monensin (CAS 17090-79-8) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MONENSIN (CAS 17090-79-8) BY GEOGRAPHIC REGION

4.1 World Historic Monensin (CAS 17090-79-8) Market Size by Geographic Region (2017-2022)
  4.1.1 Global Monensin (CAS 17090-79-8) Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Monensin (CAS 17090-79-8) Annual Revenue by Geographic Region
4.2 World Historic Monensin (CAS 17090-79-8) Market Size by Country/Region (2017-2022)
  4.2.1 Global Monensin (CAS 17090-79-8) Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Monensin (CAS 17090-79-8) Annual Revenue by Country/Region
4.3 Americas Monensin (CAS 17090-79-8) Sales Growth
4.4 APAC Monensin (CAS 17090-79-8) Sales Growth
4.5 Europe Monensin (CAS 17090-79-8) Sales Growth
4.6 Middle East & Africa Monensin (CAS 17090-79-8) Sales Growth

5 AMERICAS

5.1 Americas Monensin (CAS 17090-79-8) Sales by Country
  5.1.1 Americas Monensin (CAS 17090-79-8) Sales by Country (2017-2022)
  5.1.2 Americas Monensin (CAS 17090-79-8) Revenue by Country (2017-2022)
5.2 Americas Monensin (CAS 17090-79-8) Sales by Type
5.3 Americas Monensin (CAS 17090-79-8) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Monensin (CAS 17090-79-8) Sales by Region
  6.1.1 APAC Monensin (CAS 17090-79-8) Sales by Region (2017-2022)
  6.1.2 APAC Monensin (CAS 17090-79-8) Revenue by Region (2017-2022)
6.2 APAC Monensin (CAS 17090-79-8) Sales by Type
6.3 APAC Monensin (CAS 17090-79-8) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Monensin (CAS 17090-79-8) by Country
  7.1.1 Europe Monensin (CAS 17090-79-8) Sales by Country (2017-2022)
  7.1.2 Europe Monensin (CAS 17090-79-8) Revenue by Country (2017-2022)
7.2 Europe Monensin (CAS 17090-79-8) Sales by Type
7.3 Europe Monensin (CAS 17090-79-8) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Monensin (CAS 17090-79-8) by Country
  8.1.1 Middle East & Africa Monensin (CAS 17090-79-8) Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Monensin (CAS 17090-79-8) Revenue by Country (2017-2022)
8.2 Middle East & Africa Monensin (CAS 17090-79-8) Sales by Type
8.3 Middle East & Africa Monensin (CAS 17090-79-8) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monensin (CAS 17090-79-8)
10.3 Manufacturing Process Analysis of Monensin (CAS 17090-79-8)
10.4 Industry Chain Structure of Monensin (CAS 17090-79-8)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Monensin (CAS 17090-79-8) Distributors
11.3 Monensin (CAS 17090-79-8) Customer

12 WORLD FORECAST REVIEW FOR MONENSIN (CAS 17090-79-8) BY GEOGRAPHIC REGION

12.1 Global Monensin (CAS 17090-79-8) Market Size Forecast by Region
  12.1.1 Global Monensin (CAS 17090-79-8) Forecast by Region (2023-2028)
  12.1.2 Global Monensin (CAS 17090-79-8) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Monensin (CAS 17090-79-8) Forecast by Type
12.7 Global Monensin (CAS 17090-79-8) Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Elanco
  13.1.1 Elanco Company Information
  13.1.2 Elanco Monensin (CAS 17090-79-8) Product Offered
  13.1.3 Elanco Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Elanco Main Business Overview
  13.1.5 Elanco Latest Developments
13.2 Zoetis
  13.2.1 Zoetis Company Information
  13.2.2 Zoetis Monensin (CAS 17090-79-8) Product Offered
  13.2.3 Zoetis Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Zoetis Main Business Overview
  13.2.5 Zoetis Latest Developments
13.3 Huvepharma
  13.3.1 Huvepharma Company Information
  13.3.2 Huvepharma Monensin (CAS 17090-79-8) Product Offered
  13.3.3 Huvepharma Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Huvepharma Main Business Overview
  13.3.5 Huvepharma Latest Developments
13.4 Virbac
  13.4.1 Virbac Company Information
  13.4.2 Virbac Monensin (CAS 17090-79-8) Product Offered
  13.4.3 Virbac Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Virbac Main Business Overview
  13.4.5 Virbac Latest Developments
13.5 Merck Animal Health
  13.5.1 Merck Animal Health Company Information
  13.5.2 Merck Animal Health Monensin (CAS 17090-79-8) Product Offered
  13.5.3 Merck Animal Health Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Merck Animal Health Main Business Overview
  13.5.5 Merck Animal Health Latest Developments
13.6 Ceva Animal Health
  13.6.1 Ceva Animal Health Company Information
  13.6.2 Ceva Animal Health Monensin (CAS 17090-79-8) Product Offered
  13.6.3 Ceva Animal Health Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Ceva Animal Health Main Business Overview
  13.6.5 Ceva Animal Health Latest Developments
13.7 Phibro Animal Health
  13.7.1 Phibro Animal Health Company Information
  13.7.2 Phibro Animal Health Monensin (CAS 17090-79-8) Product Offered
  13.7.3 Phibro Animal Health Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Phibro Animal Health Main Business Overview
  13.7.5 Phibro Animal Health Latest Developments
13.8 Agrihealth
  13.8.1 Agrihealth Company Information
  13.8.2 Agrihealth Monensin (CAS 17090-79-8) Product Offered
  13.8.3 Agrihealth Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Agrihealth Main Business Overview
  13.8.5 Agrihealth Latest Developments
13.9 Qilu Pharmaceutical
  13.9.1 Qilu Pharmaceutical Company Information
  13.9.2 Qilu Pharmaceutical Monensin (CAS 17090-79-8) Product Offered
  13.9.3 Qilu Pharmaceutical Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Qilu Pharmaceutical Main Business Overview
  13.9.5 Qilu Pharmaceutical Latest Developments
13.10 CAHIC
  13.10.1 CAHIC Company Information
  13.10.2 CAHIC Monensin (CAS 17090-79-8) Product Offered
  13.10.3 CAHIC Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 CAHIC Main Business Overview
  13.10.5 CAHIC Latest Developments
13.11 Biok Biology
  13.11.1 Biok Biology Company Information
  13.11.2 Biok Biology Monensin (CAS 17090-79-8) Product Offered
  13.11.3 Biok Biology Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 Biok Biology Main Business Overview
  13.11.5 Biok Biology Latest Developments
13.12 Bio Agri Mix
  13.12.1 Bio Agri Mix Company Information
  13.12.2 Bio Agri Mix Monensin (CAS 17090-79-8) Product Offered
  13.12.3 Bio Agri Mix Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 Bio Agri Mix Main Business Overview
  13.12.5 Bio Agri Mix Latest Developments
13.13 Animate Animal Health
  13.13.1 Animate Animal Health Company Information
  13.13.2 Animate Animal Health Monensin (CAS 17090-79-8) Product Offered
  13.13.3 Animate Animal Health Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.13.4 Animate Animal Health Main Business Overview
  13.13.5 Animate Animal Health Latest Developments
13.14 Baoxiang Feed Technology
  13.14.1 Baoxiang Feed Technology Company Information
  13.14.2 Baoxiang Feed Technology Monensin (CAS 17090-79-8) Product Offered
  13.14.3 Baoxiang Feed Technology Monensin (CAS 17090-79-8) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.14.4 Baoxiang Feed Technology Main Business Overview
  13.14.5 Baoxiang Feed Technology Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Monensin (CAS 17090-79-8) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Monensin (CAS 17090-79-8) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10% Monensin
Table 4. Major Players of 20% Monensin
Table 5. Major Players of 40% Monensin
Table 6. Global Monensin (CAS 17090-79-8) Sales by Type (2017-2022) & (K MT)
Table 7. Global Monensin (CAS 17090-79-8) Sales Market Share by Type (2017-2022)
Table 8. Global Monensin (CAS 17090-79-8) Revenue by Type (2017-2022) & ($ million)
Table 9. Global Monensin (CAS 17090-79-8) Revenue Market Share by Type (2017-2022)
Table 10. Global Monensin (CAS 17090-79-8) Sale Price by Type (2017-2022) & (USD/MT)
Table 11. Global Monensin (CAS 17090-79-8) Sales by Application (2017-2022) & (K MT)
Table 12. Global Monensin (CAS 17090-79-8) Sales Market Share by Application (2017-2022)
Table 13. Global Monensin (CAS 17090-79-8) Revenue by Application (2017-2022)
Table 14. Global Monensin (CAS 17090-79-8) Revenue Market Share by Application (2017-2022)
Table 15. Global Monensin (CAS 17090-79-8) Sale Price by Application (2017-2022) & (USD/MT)
Table 16. Global Monensin (CAS 17090-79-8) Sales by Company (2020-2022) & (K MT)
Table 17. Global Monensin (CAS 17090-79-8) Sales Market Share by Company (2020-2022)
Table 18. Global Monensin (CAS 17090-79-8) Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Monensin (CAS 17090-79-8) Revenue Market Share by Company (2020-2022)
Table 20. Global Monensin (CAS 17090-79-8) Sale Price by Company (2020-2022) & (USD/MT)
Table 21. Key Manufacturers Monensin (CAS 17090-79-8) Producing Area Distribution and Sales Area
Table 22. Players Monensin (CAS 17090-79-8) Products Offered
Table 23. Monensin (CAS 17090-79-8) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Monensin (CAS 17090-79-8) Sales by Geographic Region (2017-2022) & (K MT)
Table 27. Global Monensin (CAS 17090-79-8) Sales Market Share Geographic Region (2017-2022)
Table 28. Global Monensin (CAS 17090-79-8) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Monensin (CAS 17090-79-8) Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Monensin (CAS 17090-79-8) Sales by Country/Region (2017-2022) & (K MT)
Table 31. Global Monensin (CAS 17090-79-8) Sales Market Share by Country/Region (2017-2022)
Table 32. Global Monensin (CAS 17090-79-8) Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Monensin (CAS 17090-79-8) Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Monensin (CAS 17090-79-8) Sales by Country (2017-2022) & (K MT)
Table 35. Americas Monensin (CAS 17090-79-8) Sales Market Share by Country (2017-2022)
Table 36. Americas Monensin (CAS 17090-79-8) Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Monensin (CAS 17090-79-8) Revenue Market Share by Country (2017-2022)
Table 38. Americas Monensin (CAS 17090-79-8) Sales by Type (2017-2022) & (K MT)
Table 39. Americas Monensin (CAS 17090-79-8) Sales Market Share by Type (2017-2022)
Table 40. Americas Monensin (CAS 17090-79-8) Sales by Application (2017-2022) & (K MT)
Table 41. Americas Monensin (CAS 17090-79-8) Sales Market Share by Application (2017-2022)
Table 42. APAC Monensin (CAS 17090-79-8) Sales by Region (2017-2022) & (K MT)
Table 43. APAC Monensin (CAS 17090-79-8) Sales Market Share by Region (2017-2022)
Table 44. APAC Monensin (CAS 17090-79-8) Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Monensin (CAS 17090-79-8) Revenue Market Share by Region (2017-2022)
Table 46. APAC Monensin (CAS 17090-79-8) Sales by Type (2017-2022) & (K MT)
Table 47. APAC Monensin (CAS 17090-79-8) Sales Market Share by Type (2017-2022)
Table 48. APAC Monensin (CAS 17090-79-8) Sales by Application (2017-2022) & (K MT)
Table 49. APAC Monensin (CAS 17090-79-8) Sales Market Share by Application (2017-2022)
Table 50. Europe Monensin (CAS 17090-79-8) Sales by Country (2017-2022) & (K MT)
Table 51. Europe Monensin (CAS 17090-79-8) Sales Market Share by Country (2017-2022)
Table 52. Europe Monensin (CAS 17090-79-8) Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Monensin (CAS 17090-79-8) Revenue Market Share by Country (2017-2022)
Table 54. Europe Monensin (CAS 17090-79-8) Sales by Type (2017-2022) & (K MT)
Table 55. Europe Monensin (CAS 17090-79-8) Sales Market Share by Type (2017-2022)
Table 56. Europe Monensin (CAS 17090-79-8) Sales by Application (2017-2022) & (K MT)
Table 57. Europe Monensin (CAS 17090-79-8) Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Monensin (CAS 17090-79-8) Sales by Country (2017-2022) & (K MT)
Table 59. Middle East & Africa Monensin (CAS 17090-79-8) Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Monensin (CAS 17090-79-8) Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Monensin (CAS 17090-79-8) Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Monensin (CAS 17090-79-8) Sales by Type (2017-2022) & (K MT)
Table 63. Middle East & Africa Monensin (CAS 17090-79-8) Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Monensin (CAS 17090-79-8) Sales by Application (2017-2022) & (K MT)
Table 65. Middle East & Africa Monensin (CAS 17090-79-8) Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Monensin (CAS 17090-79-8)
Table 67. Key Market Challenges & Risks of Monensin (CAS 17090-79-8)
Table 68. Key Industry Trends of Monensin (CAS 17090-79-8)
Table 69. Monensin (CAS 17090-79-8) Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Monensin (CAS 17090-79-8) Distributors List
Table 72. Monensin (CAS 17090-79-8) Customer List
Table 73. Global Monensin (CAS 17090-79-8) Sales Forecast by Region (2023-2028) & (K MT)
Table 74. Global Monensin (CAS 17090-79-8) Sales Market Forecast by Region
Table 75. Global Monensin (CAS 17090-79-8) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Monensin (CAS 17090-79-8) Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Monensin (CAS 17090-79-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 78. Americas Monensin (CAS 17090-79-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Monensin (CAS 17090-79-8) Sales Forecast by Region (2023-2028) & (K MT)
Table 80. APAC Monensin (CAS 17090-79-8) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Monensin (CAS 17090-79-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 82. Europe Monensin (CAS 17090-79-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Monensin (CAS 17090-79-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 84. Middle East & Africa Monensin (CAS 17090-79-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Monensin (CAS 17090-79-8) Sales Forecast by Type (2023-2028) & (K MT)
Table 86. Global Monensin (CAS 17090-79-8) Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Monensin (CAS 17090-79-8) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Monensin (CAS 17090-79-8) Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Monensin (CAS 17090-79-8) Sales Forecast by Application (2023-2028) & (K MT)
Table 90. Global Monensin (CAS 17090-79-8) Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Monensin (CAS 17090-79-8) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Monensin (CAS 17090-79-8) Revenue Market Share Forecast by Application (2023-2028)
Table 93. Elanco Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 94. Elanco Monensin (CAS 17090-79-8) Product Offered
Table 95. Elanco Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 96. Elanco Main Business
Table 97. Elanco Latest Developments
Table 98. Zoetis Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 99. Zoetis Monensin (CAS 17090-79-8) Product Offered
Table 100. Zoetis Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 101. Zoetis Main Business
Table 102. Zoetis Latest Developments
Table 103. Huvepharma Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 104. Huvepharma Monensin (CAS 17090-79-8) Product Offered
Table 105. Huvepharma Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 106. Huvepharma Main Business
Table 107. Huvepharma Latest Developments
Table 108. Virbac Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 109. Virbac Monensin (CAS 17090-79-8) Product Offered
Table 110. Virbac Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 111. Virbac Main Business
Table 112. Virbac Latest Developments
Table 113. Merck Animal Health Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck Animal Health Monensin (CAS 17090-79-8) Product Offered
Table 115. Merck Animal Health Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 116. Merck Animal Health Main Business
Table 117. Merck Animal Health Latest Developments
Table 118. Ceva Animal Health Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 119. Ceva Animal Health Monensin (CAS 17090-79-8) Product Offered
Table 120. Ceva Animal Health Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 121. Ceva Animal Health Main Business
Table 122. Ceva Animal Health Latest Developments
Table 123. Phibro Animal Health Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 124. Phibro Animal Health Monensin (CAS 17090-79-8) Product Offered
Table 125. Phibro Animal Health Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 126. Phibro Animal Health Main Business
Table 127. Phibro Animal Health Latest Developments
Table 128. Agrihealth Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 129. Agrihealth Monensin (CAS 17090-79-8) Product Offered
Table 130. Agrihealth Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 131. Agrihealth Main Business
Table 132. Agrihealth Latest Developments
Table 133. Qilu Pharmaceutical Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 134. Qilu Pharmaceutical Monensin (CAS 17090-79-8) Product Offered
Table 135. Qilu Pharmaceutical Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 136. Qilu Pharmaceutical Main Business
Table 137. Qilu Pharmaceutical Latest Developments
Table 138. CAHIC Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 139. CAHIC Monensin (CAS 17090-79-8) Product Offered
Table 140. CAHIC Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 141. CAHIC Main Business
Table 142. CAHIC Latest Developments
Table 143. Biok Biology Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 144. Biok Biology Monensin (CAS 17090-79-8) Product Offered
Table 145. Biok Biology Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 146. Biok Biology Main Business
Table 147. Biok Biology Latest Developments
Table 148. Bio Agri Mix Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 149. Bio Agri Mix Monensin (CAS 17090-79-8) Product Offered
Table 150. Bio Agri Mix Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 151. Bio Agri Mix Main Business
Table 152. Bio Agri Mix Latest Developments
Table 153. Animate Animal Health Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 154. Animate Animal Health Monensin (CAS 17090-79-8) Product Offered
Table 155. Animate Animal Health Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 156. Animate Animal Health Main Business
Table 157. Animate Animal Health Latest Developments
Table 158. Baoxiang Feed Technology Basic Information, Monensin (CAS 17090-79-8) Manufacturing Base, Sales Area and Its Competitors
Table 159. Baoxiang Feed Technology Monensin (CAS 17090-79-8) Product Offered
Table 160. Baoxiang Feed Technology Monensin (CAS 17090-79-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 161. Baoxiang Feed Technology Main Business
Table 162. Baoxiang Feed Technology Latest Developments

LIST OF FIGURES

Figure 1. Picture of Monensin (CAS 17090-79-8)
Figure 2. Monensin (CAS 17090-79-8) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monensin (CAS 17090-79-8) Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Monensin (CAS 17090-79-8) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Monensin (CAS 17090-79-8) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10% Monensin
Figure 10. Product Picture of 20% Monensin
Figure 11. Product Picture of 40% Monensin
Figure 12. Global Monensin (CAS 17090-79-8) Sales Market Share by Type in 2021
Figure 13. Global Monensin (CAS 17090-79-8) Revenue Market Share by Type (2017-2022)
Figure 14. Monensin (CAS 17090-79-8) Consumed in Cattle
Figure 15. Global Monensin (CAS 17090-79-8) Market: Cattle (2017-2022) & (K MT)
Figure 16. Monensin (CAS 17090-79-8) Consumed in Sheep
Figure 17. Global Monensin (CAS 17090-79-8) Market: Sheep (2017-2022) & (K MT)
Figure 18. Monensin (CAS 17090-79-8) Consumed in Chicken
Figure 19. Global Monensin (CAS 17090-79-8) Market: Chicken (2017-2022) & (K MT)
Figure 20. Monensin (CAS 17090-79-8) Consumed in Others
Figure 21. Global Monensin (CAS 17090-79-8) Market: Others (2017-2022) & (K MT)
Figure 22. Global Monensin (CAS 17090-79-8) Sales Market Share by Application (2017-2022)
Figure 23. Global Monensin (CAS 17090-79-8) Revenue Market Share by Application in 2021
Figure 24. Monensin (CAS 17090-79-8) Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Monensin (CAS 17090-79-8) Revenue Market Share by Company in 2021
Figure 26. Global Monensin (CAS 17090-79-8) Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Monensin (CAS 17090-79-8) Revenue Market Share by Geographic Region in 2021
Figure 28. Global Monensin (CAS 17090-79-8) Sales Market Share by Region (2017-2022)
Figure 29. Global Monensin (CAS 17090-79-8) Revenue Market Share by Country/Region in 2021
Figure 30. Americas Monensin (CAS 17090-79-8) Sales 2017-2022 (K MT)
Figure 31. Americas Monensin (CAS 17090-79-8) Revenue 2017-2022 ($ Millions)
Figure 32. APAC Monensin (CAS 17090-79-8) Sales 2017-2022 (K MT)
Figure 33. APAC Monensin (CAS 17090-79-8) Revenue 2017-2022 ($ Millions)
Figure 34. Europe Monensin (CAS 17090-79-8) Sales 2017-2022 (K MT)
Figure 35. Europe Monensin (CAS 17090-79-8) Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Monensin (CAS 17090-79-8) Sales 2017-2022 (K MT)
Figure 37. Middle East & Africa Monensin (CAS 17090-79-8) Revenue 2017-2022 ($ Millions)
Figure 38. Americas Monensin (CAS 17090-79-8) Sales Market Share by Country in 2021
Figure 39. Americas Monensin (CAS 17090-79-8) Revenue Market Share by Country in 2021
Figure 40. United States Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Monensin (CAS 17090-79-8) Sales Market Share by Region in 2021
Figure 45. APAC Monensin (CAS 17090-79-8) Revenue Market Share by Regions in 2021
Figure 46. China Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Monensin (CAS 17090-79-8) Sales Market Share by Country in 2021
Figure 53. Europe Monensin (CAS 17090-79-8) Revenue Market Share by Country in 2021
Figure 54. Germany Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Monensin (CAS 17090-79-8) Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Monensin (CAS 17090-79-8) Revenue Market Share by Country in 2021
Figure 61. Egypt Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Monensin (CAS 17090-79-8) Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Monensin (CAS 17090-79-8) in 2021
Figure 67. Manufacturing Process Analysis of Monensin (CAS 17090-79-8)
Figure 68. Industry Chain Structure of Monensin (CAS 17090-79-8)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


More Publications